W
GILD icon

WealthCollab’s Gilead Sciences GILD Stock Holding History

WealthCollab’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.7K Sell
322
-5
-2% -$659 0.01% 267
2026
Q1 		$45.6K Hold
327
– – 0.02% 218
2025
Q4 		$40.1K Hold
327
– – 0.02% 251
2025
Q3 		$36.3K Hold
327
– – 0.02% 241
2025
Q2 		$36.3K Hold
327
– – 0.02% 221
2025
Q1 		$36.6K Buy
327
+4
+1% +$413 0.02% 206
2024
Q4 		$29.8K Hold
323
– – 0.02% 238
2024
Q3 		$27.1K Sell
323
-56
-15% -$4.27K 0.02% 260
2024
Q2 		$26K Sell
379
-75
-17% -$5K 0.02% 248
2024
Q1 		$33.3K Hold
454
– – 0.02% 203
2023
Q4 		$36.8K Buy
+454
New +$35.3K 0.03% 164

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WealthCollab's GILD Position: Q2 2026 in Review

WealthCollab reduced its Gilead Sciences (GILD) stake by 1.5% in Q2 2026, selling an estimated $659 and leaving 322 shares worth $40.7K. The position accounts for 0.01% of the portfolio, ranked #267.

WealthCollab first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $45.6K in Q1 2026. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • WealthCollab held 322 shares of Gilead Sciences worth $40.7K as of Q2 2026.
  • WealthCollab sold 5 Gilead Sciences shares in Q2 2026, an estimated $659.
  • Gilead Sciences made up 0.01% of WealthCollab's portfolio in Q2 2026, its #267 holding.
  • WealthCollab first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • WealthCollab's Gilead Sciences position peaked at $45.6K in Q1 2026.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.